§ Same category · GLP-1 / metabolic peptides
Mazdutide vs Tirzepatide
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Mazdutide
5
vendors tracked
from $5.72/mg
Tirzepatide
8
vendors tracked
from $2.08/mg
◎ Cheapest $/mg:Tirzepatide at $2.08/mg
Mazdutide
GLP-1/glucagon dual agonist
B-
Operational$57.20
$5.72/mg
Out of stockOn sale
B
Operational$79.99
$8.00/mg
In stock▲ 39.8% vs best
Operational
$249.99
$25.00/mg
In stock▲ 337.0% vs best
| Vendor | Grade | Risk | Price | $/mg | Trend | Stock | |
|---|---|---|---|---|---|---|---|
| Southern Aminos US | B- | Operational | $57.20 On sale | $5.72 | Out | Buy with code → | |
| Welli Labs US | B | Operational | $79.99 ▲ 39.8% | $8.00 | In stock | Visit → | |
| Pure Lab Peptides US | B- | Operational | $249.99 ▲ 337.0% | $25.00 | In stock | Visit → |
Sort:
Last crawl 2026-08-12Sort:
2026-08-12Tirzepatide
Dual GLP-1/GIP agonist
B-
Operational$24.00
$2.40/mg
In stock◎ Best $/mg
B
Operational$39.99
$4.00/mg
In stock▲ 66.6% vs best
Operational
$89.99
$9.00/mg
In stock▲ 275.0% vs best
B-
Operational$99.00
$9.90/mg
In stock▲ 312.5% vs best
Watch
$99.99
$10.00/mg
In stock▲ 316.6% vs best
Operational
$199.99
$20.00/mg
In stock▲ 733.3% vs best
| Vendor | Grade | Risk | Price | $/mg | Trend | Stock | |
|---|---|---|---|---|---|---|---|
| RetaOneLabs US | B- | Operational | $24.00 ◎ Best $/mg | $2.40 | In stock | Buy with code → | |
| Welli Labs US | B | Operational | $39.99 ▲ 66.6% | $4.00 | In stock | Visit → | |
| One Day Compounds US | B- | Operational | $89.99 ▲ 275.0% | $9.00 | In stock | Visit → | |
| Atomik Labz US | B- | Operational | $99.00 ▲ 312.5% | $9.90 | In stock | Visit → | |
| Felix Chemical Supply US | B- | Watch | $99.99 ▲ 316.6% | $10.00 | In stock | Visit → | |
| Pure Lab Peptides US | B- | Operational | $199.99 ▲ 733.3% | $20.00 | In stock | Visit → |
Sort:
Last crawl 2026-08-12Sort:
2026-08-12About Mazdutide
A dual GLP-1 and glucagon receptor agonist in late-stage clinical development for obesity, type-2 diabetes, and metabolic-associated fatty liver disease.
About Tirzepatide
A once-weekly dual GIP and GLP-1 receptor agonist studied for type-2 diabetes and obesity. Approved clinically in many jurisdictions; research-compound form is widely distributed.